WallStreetZenWallStreetZen

NASDAQ: AXGN
Axogen Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for AXGN

Based on 2 analysts offering 12 month price targets for Axogen Inc.
Min Forecast
$14.00+30.35%
Avg Forecast
$14.50+35.01%
Max Forecast
$15.00+39.66%

Should I buy or sell AXGN stock?

Based on 2 analysts offering ratings for Axogen Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AXGN stock forecasts and price targets.

AXGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Top 14%
87
Strong BuyUpgrades$15.00+39.66%2022-05-09Find out why
SVB Leerink
Bottom 3%
3
BuyMaintains$14.00+30.35%2022-05-05
Anonymous
JMP Securities
BuyMaintains$20.00+86.22%2021-11-04

1 of 1

Forecast return on equity

Is AXGN forecast to generate an efficient return?
Company
-17.46%
Industry
24.32%
Market
118.57%
AXGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AXGN forecast to generate an efficient return on assets?
Company
-9.06%
Industry
13.22%
AXGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AXGN earnings per share forecast

What is AXGN's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.62
Avg 2 year Forecast
-$0.38
Avg 3 year Forecast
-$0.51

AXGN revenue forecast

What is AXGN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$139.3M+8.66%
Avg 2 year Forecast
$172.0M+34.16%
Avg 3 year Forecast
$208.0M+62.24%
AXGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AXGN revenue growth forecast

How is AXGN forecast to perform vs Medical Devices companies and vs the US market?
Company
17.4%
Industry
4.76%
Market
8.46%
AXGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AXGN$10.74$14.50+35.01%Strong Buy
RBOT$3.61$11.60+221.33%Buy
MASS$15.18$30.00+97.63%Buy
SDC$1.06$2.32+118.58%Hold
OFIX$19.98$45.00+125.23%Strong Buy

Axogen Stock Forecast FAQ

Is Axogen Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AXGN) stock is to Strong Buy AXGN stock.

Out of 2 analysts, 1 (50%) are recommending AXGN as a Strong Buy, 1 (50%) are recommending AXGN as a Buy, 0 (0%) are recommending AXGN as a Hold, 0 (0%) are recommending AXGN as a Sell, and 0 (0%) are recommending AXGN as a Strong Sell.

If you're new to stock investing, here's how to buy Axogen stock.

What is AXGN's earnings growth forecast for 2022-2024?

(NASDAQ: AXGN) Axogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 19.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Axogen's earnings in 2022 is -$31,642,000.On average, 2 Wall Street analysts forecast AXGN's earnings for 2022 to be -$26,215,903, with the lowest AXGN earnings forecast at -$31,289,949, and the highest AXGN earnings forecast at -$20,719,020. On average, 2 Wall Street analysts forecast AXGN's earnings for 2023 to be -$16,067,812, with the lowest AXGN earnings forecast at -$24,101,718, and the highest AXGN earnings forecast at -$8,033,906.

In 2024, AXGN is forecast to generate -$21,564,695 in earnings, with the lowest earnings forecast at -$21,564,695 and the highest earnings forecast at -$21,564,695.

What is AXGN's revenue growth forecast for 2022-2024?

(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 17.4% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.76%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Axogen's revenue in 2022 is $128,202,000.On average, 1 Wall Street analysts forecast AXGN's revenue for 2022 to be $5,890,121,500, with the lowest AXGN revenue forecast at $5,890,121,500, and the highest AXGN revenue forecast at $5,890,121,500. On average, 1 Wall Street analysts forecast AXGN's revenue for 2023 to be $7,272,798,980, with the lowest AXGN revenue forecast at $7,272,798,980, and the highest AXGN revenue forecast at $7,272,798,980.

In 2024, AXGN is forecast to generate $8,795,012,720 in revenue, with the lowest revenue forecast at $8,795,012,720 and the highest revenue forecast at $8,795,012,720.

What is AXGN's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: AXGN) forecast ROA is -9.06%, which is lower than the forecast US Medical Devices industry average of 13.22%.

What is AXGN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AXGN price target, the average AXGN price target is $14.50, with the highest AXGN stock price forecast at $15.00 and the lowest AXGN stock price forecast at $14.00.

On average, Wall Street analysts predict that Axogen's share price could reach $14.50 by May 9, 2023. The average Axogen stock price prediction forecasts a potential upside of 35.01% from the current AXGN share price of $10.74.

What is AXGN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: AXGN) Axogen's current Earnings Per Share (EPS) is -$0.74. On average, analysts forecast that AXGN's EPS will be -$0.62 for 2022, with the lowest EPS forecast at -$0.74, and the highest EPS forecast at -$0.49. On average, analysts forecast that AXGN's EPS will be -$0.38 for 2023, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.19. In 2024, AXGN's EPS is forecast to hit -$0.51 (min: -$0.51, max: -$0.51).

What is AXGN's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: AXGN) forecast ROE is -17.46%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.